Sucralfate: nonulcer uses. American College of Gastroenterology Committee on FDA-Related Matters
Brooks, W.S.
American Journal of Gastroenterology 80(3): 206-209
1985
ISSN/ISBN: 0002-9270 PMID: 3838414 Document Number: 267331
Recent studies have shown sucralfate to have cytoprotective features in addition to its known antipepsin and antacid effects. This drug has been shown in limited studies to prevent gastric salicylate injury with pretreatment. A role for sucralfate in the nonulcer population, patients with gastritis, esophagitis, stomatitis, while promising, has not been clearly established and needs to be defined with further studies.